MOVANTIK™ (naloxegol) + Sugar Pill
ApprovedTerminated 1 views this week 0 watching💤 Quiet
Interest: 35/100
35
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Constipation
Conditions
Constipation
Trial Timeline
Jan 1, 2017 → Feb 1, 2018
NCT ID
NCT02946580About MOVANTIK™ (naloxegol) + Sugar Pill
MOVANTIK™ (naloxegol) + Sugar Pill is a approved stage product being developed by AstraZeneca for Constipation. The current trial status is terminated. This product is registered under clinical trial identifier NCT02946580. Target conditions include Constipation.
What happened to similar drugs?
20 of 20 similar drugs in Constipation were approved
Approved (20) Terminated (4) Active (0)
Hype Score Breakdown
Clinical
20
Activity
0
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02946580 | Approved | Terminated |
Competing Products
20 competing products in Constipation